clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications
Coronavirus
AI Effectively Allocates Resources in Pandemic
News & Features
New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease
News & Features
AFib Three Times More Common than Thought
News & Features
Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Authors
Posts by Patricia Fitzpatrick Dimond, Ph.D.
Patricia Fitzpatrick Dimond, Ph.D.
21 POSTS
0 COMMENTS
Ph.D.
Molecular Dx
Precision Biomarkers and Medicines Go Global
November 1, 2018
Molecular Dx
Tumor Biomarkers Culled from Errant Transcripts
February 7, 2018
Molecular Dx
Multiplexed Sequencing for Novel Viral Pathogens
June 1, 2016
Informatics
Big Data’s Big Implications for Cancer Treatments
May 2, 2016
Molecular Dx
Finer Cancer Screens Catch More Cancer Clues
March 31, 2016
Molecular Dx
Clinical Actionability in Cancer
February 29, 2016
Molecular Dx
Proteomics for Disease Detection and Characterization
January 29, 2016
News & Features
Precision Medicine in Oncology
January 4, 2016
Molecular Dx
Identifying Susceptibility Genes and Epigenetic Mechanisms for Drugs of Abuse
November 30, 2015
Molecular Dx
Companion Diagnostics for Cancer: Will NGS Play a Role?
October 30, 2015
1
2
3
Page 1 of 3
Related Content
Five Features Underlie Immunotherapy Response
International Survey Highlights Suboptimal Uptake of Lung Cancer Biomarker Testing
Cancer Trials Exclude Individuals of African and Middle Eastern Ancestry Due to Duffy Blood Group
COPD Flare Ups Can Be Detected from Voice Changes Recorded on a Cell Phone
Inside Precision Medicine
![One key outcome of the use of mass spec in the NIH’s Clinical Proteomic Technologies for Cancer program has been the improvement of the proteomic biomarker development pipeline. [iStock / nan_bkk]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/487-324x160.jpeg "Proteomics for Disease Detection and Characterization")
![The White House has proposed $70 million in increased funding for the National Cancer Institute to advance the field of precision oncology. [iStock/KatarzynaBialasiewicz]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/446-324x160.jpeg "Precision Medicine in Oncology")
![Pharmaceutical manufacturers have found that using companion diagnostics during drug development improves the success rate of therapeutics being tested in clinical trials. [iStock/anna1311]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/355-324x160.jpeg "Companion Diagnostics for Cancer: Will NGS Play a Role?")
